Nymox Pharmaceutical (NYMXF)
OTHER OTC:NYMXF
US Market
Holding NYMXF?
Track your performance easily

Nymox Pharmaceutical (NYMXF) Financial Statements

141 Followers

Nymox Pharmaceutical Financial Overview

Nymox Pharmaceutical's market cap is currently ―. The company's EPS TTM is $-0.095; its P/E ratio is -1.05; Nymox Pharmaceutical is scheduled to report earnings on May 15, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 22Sep 22Jun 22Mar 22Dec 21
Income Statement-
Total Revenue-$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit-$ 0.00$ 0.00$ 0.00$ 0.00
EBIT-$ -1.48M$ -1.78M$ -5.07M$ -2.77M
EBITDA-$ -1.42M$ -1.71M$ -5.01M$ -2.70M
Net Income Common Stockholders-$ -1.49M$ 1.34M$ -5.09M$ -2.81M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 1.40M$ 2.70M$ 4.07M$ 672.00K$ 830.00K
Total Assets$ 1.63M$ 3.14M$ 4.47M$ 1.24M$ 1.44M
Total Debt$ 0.00$ 227.00K$ 284.00K$ 339.00K$ 391.00K
Net Debt$ -1.40M$ -2.48M$ -3.79M$ -333.00K$ -439.00K
Total Liabilities$ 2.11M$ 2.37M$ 2.24M$ 2.63M$ 1.95M
Stockholders Equity$ -172.15M$ 773.00K$ 2.23M$ -1.39M$ -506.00K
Cash Flow-
Free Cash Flow-$ -1.31M$ 1.56M$ -4.21M$ -2.25M
Operating Cash Flow-$ -1.31M$ 1.56M$ -4.21M$ -2.25M
Investing Cash Flow-$ 0.00$ 0.00$ 0.00$ -4.00K
Financing Cash Flow-$ -60.00K$ 1.84M$ 4.05M$ -59.00K
Currency in USD

Nymox Pharmaceutical Earnings and Revenue History

Nymox Pharmaceutical Debt to Assets

Nymox Pharmaceutical Cash Flow

Nymox Pharmaceutical Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis